DE2530246C2 - - Google Patents
Info
- Publication number
- DE2530246C2 DE2530246C2 DE19752530246 DE2530246A DE2530246C2 DE 2530246 C2 DE2530246 C2 DE 2530246C2 DE 19752530246 DE19752530246 DE 19752530246 DE 2530246 A DE2530246 A DE 2530246A DE 2530246 C2 DE2530246 C2 DE 2530246C2
- Authority
- DE
- Germany
- Prior art keywords
- weight
- amino acid
- acid mixture
- mixture according
- methionine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 150000008575 L-amino acids Chemical class 0.000 claims 5
- 239000000203 mixture Substances 0.000 claims 4
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims 2
- FFEARJCKVFRZRR-UHFFFAOYSA-N L-Methionine Natural products CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 claims 2
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 claims 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims 2
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims 2
- 229930195722 L-methionine Natural products 0.000 claims 2
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims 2
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims 2
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims 2
- 229960004452 methionine Drugs 0.000 claims 2
- QDGAVODICPCDMU-UHFFFAOYSA-N 2-amino-3-[3-[bis(2-chloroethyl)amino]phenyl]propanoic acid Chemical compound OC(=O)C(N)CC1=CC=CC(N(CCCl)CCCl)=C1 QDGAVODICPCDMU-UHFFFAOYSA-N 0.000 claims 1
- 208000009304 Acute Kidney Injury Diseases 0.000 claims 1
- 235000013878 L-cysteine Nutrition 0.000 claims 1
- 239000004201 L-cysteine Substances 0.000 claims 1
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 claims 1
- 235000019393 L-cystine Nutrition 0.000 claims 1
- 239000004158 L-cystine Substances 0.000 claims 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims 1
- 229930182844 L-isoleucine Natural products 0.000 claims 1
- 235000019454 L-leucine Nutrition 0.000 claims 1
- 239000004395 L-leucine Substances 0.000 claims 1
- 208000033626 Renal failure acute Diseases 0.000 claims 1
- 239000004473 Threonine Substances 0.000 claims 1
- 230000001154 acute effect Effects 0.000 claims 1
- 201000011040 acute kidney failure Diseases 0.000 claims 1
- 208000012998 acute renal failure Diseases 0.000 claims 1
- 208000020832 chronic kidney disease Diseases 0.000 claims 1
- 208000022831 chronic renal failure syndrome Diseases 0.000 claims 1
- 229960003067 cystine Drugs 0.000 claims 1
- 229960002885 histidine Drugs 0.000 claims 1
- 229960000310 isoleucine Drugs 0.000 claims 1
- 229960003136 leucine Drugs 0.000 claims 1
- WPLOVIFNBMNBPD-ATHMIXSHSA-N subtilin Chemical compound CC1SCC(NC2=O)C(=O)NC(CC(N)=O)C(=O)NC(C(=O)NC(CCCCN)C(=O)NC(C(C)CC)C(=O)NC(=C)C(=O)NC(CCCCN)C(O)=O)CSC(C)C2NC(=O)C(CC(C)C)NC(=O)C1NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C1NC(=O)C(=C/C)/NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C2NC(=O)CNC(=O)C3CCCN3C(=O)C(NC(=O)C3NC(=O)C(CC(C)C)NC(=O)C(=C)NC(=O)C(CCC(O)=O)NC(=O)C(NC(=O)C(CCCCN)NC(=O)C(N)CC=4C5=CC=CC=C5NC=4)CSC3)C(C)SC2)C(C)C)C(C)SC1)CC1=CC=CC=C1 WPLOVIFNBMNBPD-ATHMIXSHSA-N 0.000 claims 1
- 229960002898 threonine Drugs 0.000 claims 1
- 229960004799 tryptophan Drugs 0.000 claims 1
- 229960004441 tyrosine Drugs 0.000 claims 1
- 229960004295 valine Drugs 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19752530246 DE2530246A1 (de) | 1975-07-07 | 1975-07-07 | L-aminosaeuregemische fuer parenterale oder orale anwendung |
| FR7620325A FR2316933A1 (fr) | 1975-07-07 | 1976-07-02 | Melanges de l-aminoacides et leur utilisation therapeutique pour le traitement d'insuffisances hepatiques et renales. |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19752530246 DE2530246A1 (de) | 1975-07-07 | 1975-07-07 | L-aminosaeuregemische fuer parenterale oder orale anwendung |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE2530246A1 DE2530246A1 (de) | 1977-01-13 |
| DE2530246C2 true DE2530246C2 (enExample) | 1989-08-03 |
Family
ID=5950870
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19752530246 Granted DE2530246A1 (de) | 1975-07-07 | 1975-07-07 | L-aminosaeuregemische fuer parenterale oder orale anwendung |
Country Status (2)
| Country | Link |
|---|---|
| DE (1) | DE2530246A1 (enExample) |
| FR (1) | FR2316933A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2531204C2 (de) * | 1975-07-12 | 1987-01-22 | Fresenius AG, 6380 Bad Homburg | L-Aminosäuregemische für die parenterale oder orale Ernährung |
| JPS5535049A (en) * | 1978-09-04 | 1980-03-11 | Otsuka Pharmaceut Factory Inc | Amino acid transfusion for cancerous patient |
| JPS5536457A (en) * | 1978-09-08 | 1980-03-14 | Ajinomoto Co Inc | Amino acid infusion |
| JPS58126767A (ja) * | 1982-01-22 | 1983-07-28 | Ajinomoto Co Inc | 肝臓病患者用栄養組成物 |
| JPS5916817A (ja) * | 1982-07-16 | 1984-01-28 | Eisai Co Ltd | アミノ酸輸液 |
| US5646187A (en) * | 1992-05-20 | 1997-07-08 | Ab Erik Vinnars | Use of alpha-ketoglutarate |
| IT1289754B1 (it) * | 1996-12-16 | 1998-10-16 | Professional Dietetics Srl | Composizioni a base di aminoacidi |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1667887C2 (de) * | 1968-02-09 | 1978-09-28 | Knauff, Hans Georg, Prof. Dr., 3551 Dagobertshausen | Aminosäurelösung zur parenteralen Infusion |
| AT297935B (de) * | 1968-05-09 | 1972-04-10 | Astra Ab | Verfahren zur Herstellung einer Infusionslösung von essentiellen Aminosäuren zur intravenösen Zufuhr bei urämischen Zuständen |
| US3832465A (en) * | 1971-12-09 | 1974-08-27 | H Ghadimi | Injectable amino acid composition commensurate to the anabolic need of the body and method of using same |
| GB1356370A (en) * | 1972-03-06 | 1974-06-12 | Howard A N | Methods and formulations for the treatment of obesity |
| DE2335215B2 (de) * | 1972-07-13 | 1979-04-05 | The Johns Hopkins University, Baltimore, Md. (V.St.A.) | Verwendung einer Mischung bei der Bekämpfung von zur Urämie führenden Nierenerkrankungen |
| FR2215212B1 (enExample) * | 1973-01-18 | 1976-03-05 | Seperic Ch | |
| GB1442154A (en) * | 1973-04-30 | 1976-07-07 | Walser M | Composition for promotion of protein synthesis and suppression of urea formation in the body |
-
1975
- 1975-07-07 DE DE19752530246 patent/DE2530246A1/de active Granted
-
1976
- 1976-07-02 FR FR7620325A patent/FR2316933A1/fr active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| FR2316933A1 (fr) | 1977-02-04 |
| DE2530246A1 (de) | 1977-01-13 |
| FR2316933B1 (enExample) | 1979-06-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2530246C2 (enExample) | ||
| ATA925175A (de) | Verfahren zur herstellung von neuen, racemischen oder in der l-form vorliegenden 5-hydroxypropionylamino-2,4,6-trijod-isophthalsaure-bis- (dihydroxypropylamiden) | |
| JPS52116465A (en) | Peptides | |
| IE39051B1 (en) | New peptides and processes for their manufacture | |
| ATE190466T1 (de) | Fungizide zwei- und dreikomponentenmischungen | |
| ATE3860T1 (de) | Verfahren zur herstellung von imidazolidinderivaten. | |
| IE34673L (en) | Peptide sweetening agents | |
| ATA908974A (de) | Pulvermischung zur herstellung von legierungsstahl mit einem niedrigen gehalt an oxidischen einschlussen | |
| ES424240A1 (es) | Procedimiento para realzar el tiempo de fraguado abierto decomposiciones de cemento hidraulicas. | |
| FR2317917A1 (fr) | Melanges de l-aminoacides et leur utilisation therapeutique | |
| GB1496254A (en) | Nutritive infusion solution and its production | |
| GB1444621A (en) | Composition for promotion of protein synthesis and suppression of urea formation in the body utilizing alpha-hydroxy-acid analogues of amino acids | |
| ATA603477A (de) | Verfahren zur herstellung von dinitroanthrachinon-gemischen mit einem 1,5- und 1,8-dinitroanthrachinon-gehalt von 70 bis 80 gew.-% | |
| FR2070149A1 (en) | Hypocalcemiant calcitonin m derivatives | |
| GB1398819A (en) | Pharmaceutical compositions containing sulphoglycopeptide salts | |
| JPS5232046A (en) | Polyamide composition | |
| JPS5738709A (en) | Composition for oral purpose | |
| JPS5221054A (en) | Polyamide composition | |
| Vorob'yev et al. | Dynamics of Some Trace Elements in Organs and Tissues of the Rudd | |
| SU487090A1 (ru) | Поливинилхлоридна композици | |
| KR950030833A (ko) | 타우린(Taurine)을 다량함유한 계란의 생산방법 및 사료첨가제 | |
| JPS5225768A (en) | Preparation of novel pentapeptides | |
| Matuno | On the Essential Amino Acid Intake of the Japanese People (Report 12) Intake of the Essential Amino Acid from Animal Origin and Vegetable Origin by the Japanese People Calculated from the National Nutrition Survey in Japan from 1946 to 1973 | |
| Duarte | The ichthyoplankton of the Albufeira Lagoon(1984/1985). | |
| JPS52127927A (en) | Thermosetting coating compositions |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8125 | Change of the main classification |
Ipc: A61K 31/195 |
|
| 8126 | Change of the secondary classification |
Ipc: A61K 31/40 |
|
| 8127 | New person/name/address of the applicant |
Owner name: FRESENIUS AG, 6380 BAD HOMBURG, DE |
|
| D2 | Grant after examination | ||
| 8363 | Opposition against the patent |